Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3)

Biological Psychiatry

Volumn 46, Issue 2, 1999, Pages 151-160

  Kang, A Min ^a   Palmatier, Meg A ^b   Kidd, Kenneth K ^b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allele frequencies; DAT; Dopamine transporter; Population genetics; SLC6A3; VNTR polymorphism

Indexed keywords

DOPAMINE TRANSPORTER;

ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; DOPAMINERGIC SYSTEM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ALLELES; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL LINE; CELLS, CULTURED; DNA PRIMERS; DOPAMINE; GENE FREQUENCY; GENES; GENOTYPE; MESENCEPHALON; MINISATELLITE REPEATS; NEURONS; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; PROTEIN BIOSYNTHESIS; SUBSTANCE-RELATED DISORDERS; SYNAPSES; VARIATION (GENETICS); WORLD HEALTH;

EID: 0032988185     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00101-8     Document Type: Article

References (55)

1. Boado R.J., Pardridge W.M. Ten nucleotide cis element in the 3′-untranslated region of the GLUT1 glucose transporter mRNA increases gene expression via mRNA stabilization. Brain Res Mol Brain Res. 59:1998;109-113.
2. Bodeau-Péan S., Laurent C., Campion D., Jay M., Thibaut F., Dollfus S., et al. No evidence for linkage or association between the dopamine transporter gene and schizophrenia in a French population. Psychiatry Res. 59:1995;1-6.
3. Byerley W., Hoff M., Holik J., Caron M.G., Giros B. VNTR polymorphism for the human dopamine transporter gene (DAT1). Hum Mol Genet. 2:1993;335.
4. Calafell F., Shuster A., Speed W.C., Kidd J.R., Kidd K.K. Short tandem repeat polymorphism evolution in humans. Eur J Hum Genet. 6:1998;38-49.
5. Chang F.-M., Kidd J.R., Livak K.J., Pakstis A.J., Kidd K.K. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet. 98:1996;91-101.
6. Church D.M., Bengtsson U., Nielsen K.V., Wasmuth J.J., Niebuhr E. Molecular definition of deletions of different segments of distal 5p that result in distinct phenotypic features. Am J Hum Genet. 56:1995;1162-1172.
7. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., et al. The dopamine transporter Immunochemical characterization and localization in brain . J Neurosci. 15:1995;1714-1723.
8. Comings D.E., Wu S., Chiu C., Ring R.H., Gade R., Ahn C., et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder The additive and subtractive effect of the three dopaminergic genes - DRD2, DβH, and DAT1 . Am J Med Genet (Neuropsychiatr Genet). 67:1996;264-288.
9. Cook E.H.J., Stein M.A., Krasowski M.D., Cox N.J., Olkon D.M., Kieffer J.E., et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 56:1995;993-998.
10. Donovan D.M., Vandenbergh D.J., Perry M.P., Bird G.S., Ingersoll R., Nanthakumar E., et al. Human and mouse dopamine transporter genes Conservation of 5′-flanking sequence elements and gene structures . Brain Res Mol Brain Res. 30:1995;327-335.
11. Doucette-Stamm L.A., Blakely D.J., Tian J., Mockus S., Mao J.-I. Population genetic study of the human dopamine transporter gene (DAT1). Genet Epidemiol. 12:1995;303-308.
12. Gainetdinov R.R., Fumagalli F., Jones S.R., Caron M.G. Dopamine transporter is required for in vivo MPTP neurotoxicity Evidence from mice lacking the transporter . J Neurochem. 69:1997;1322-1325.
13. Garris P.A., Wightman R.M. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum An in vivo voltammetric study . J Neurosci. 14:1994;442-450.
14. Gelernter J., Kennedy J.L., Van Tol H.H.M., Kidd K.K. The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics. 13:1992;208-210.
15. Gelernter J., Kranzler H., Lacobelle J. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), μ opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). Genomics. 1998:1998;289-297.
16. Gelernter J., Kranzler H.R., Satel S.L., Rao P.A. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology. 11:1994;195-200.
17. Gelernter J., Vandenburgh D., Kruger S.D., Pauls D.L., Kurlan R., Pakstis A.J., et al. The dopamine transporter protein gene (SLC6A3) Primary linkage mapping and linkage studies in Tourette syndrome . Genomics. 30:1995;459-463.
18. Gill M., Daly G., Heron S., Hawi Z., Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry. 2:1997;311-313.
19. Giros B., El Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol. 42:1992;383-390.
20. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
21. Inada T., Sugita T., Dobashi I., Inagaki A., Kitao Y., Matsuda G., et al. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode. Am J Med Genet (Neuropsychiatr Genet). 67:1996;406-408.
22. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci. 18:1998;1979-1986.
23. Jönsson E.G., Nöthen M.M., Gustavsson J.P., Neidt H., Bunzel R., Propping P., et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Res. 79:1998;1-9.
24. Kawarai T., Kawakami H., Yamamura Y., Nakamura S. Structure and organization of the gene encoding human dopamine transporter. Gene. 195:1997;11-18.
25. Kelsoe J.R., Sadovnick A.D., Kristbjarnarson H., Bergesch P., Mroczkowski-Parker Z., Drennan M., et al. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet. 67:1996;533-540.
26. Kidd JR, Pakstis AJ, Kidd KK (1993): Global levels of DNA variation. The Fourth International Symposium on Human Identification. Madison, WI: Promega Corporation, pp 21-30.
27. Kidd K.K., Morar B., Castiglione C.M., Zhao H., Pakstis A.J., Speed W.C., et al. A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet. 103:1998;211-227.
28. King N., Bassett A.S., Honer W.G., Masellis M., Kennedy J.L. Absence of linkage for schizophrenia on the short arm of chromosome 5 in multiplex Canadian families. Am J Med Genet (Neuropsychiatr Genet). 74:1997;472-474.
29. Le Couteur D.G., Leighton P.W., McCann S.J., Pond S.M. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease. Mov Disord. 12:1997;760-763.
30. Leighton P.W., Le Couteur D.G., Pang C.C.P., McCann S.J., Chan D., Law L.K., et al. The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology. 49:1997;1577-1579.
31. Lerman C., Caporaso N.E., Audrain J., Main D., Bowman E.D., Lockshin B., et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 18:1999;14-20.
32. Li T., Yang L., Wiese C., Xu C.T., Zeng Z., Giros B., et al. No association between alleles or genotypes at the dopamine transporter gene and schizophrenia. Psychiatry Res. 52:1994;17-23.
33. Lichter J.B., Barr C.L., Kennedy J.L., Van Tol H.H.M., Kidd K.K., Livak K.J. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet. 2:1993;767-773.
34. Muramatsu T., Higuchi S. Dopamine transporter gene polymorphism and alcoholism. Biochem Biophys Res Commun. 211:1995;28-32.
35. Nakatome M., Honda K., Islam M.N., Terada M., Yamazaki M., Kuroki H., et al. Amplification of DAT1 (human dopamine transporter gene) 3′ variable region in the Japanese population. Hum Hered. 45:1995;262-265.
36. Nakatome M., Honda K., Tun Z., Kato Y., Harihara S., Omoto K., et al. Genetic polymorphism of the 3′ VNTR region of the human dopaminergic function gene DAT1 (human dopamine transporter gene) in the Mongolian population. Hum Biol. 68:1996;509-515.
37. Palmatier MA, Kang AM, Kidd KK (in press): Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry.
38. Parsian A., Zhang Z.H. Human dopamine transporter gene polymorphism (VNTR) and alcoholism. Am J Med Genet (Neuropsychiatr Genet). 74:1997;480-482.
39. Persico A.M., Bird G., Gabbay F.H., Uhl G.R. D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms Enhanced frequencies in psychostimulant-preferring polysubstance abusers . Biol Psychiatry. 40:1996;776-784.
40. Persico A.M., Catalano M. Lack of association between dopamine transporter gene polymorphisms and delusional disorder. Am J Med Genet (Neuropsychiatr Genet). 81:1998;163-165.
41. Persico A.M., Macciardi F. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia. Am J Med Genet (Neuropsychiatr Genet). 74:1997;53-57.
42. Persico A.M., Vandenbergh D.J., Smith S.S., Uhl G.R. Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol Psychiatry. 34:1993;265-267.
43. Persico A.M., Wang Z.W., Black D.W., Andreasen N.C., Uhl G.R., Crowe R.R. Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders. Am J Psychiatr. 152:1995;134-136.
44. Sabol S.Z., Nelson M.L., Gunzerath L., Brody C.L., Hu S., Sirota L.A., et al. A genetic association for cigarette smoking behavior. Health Psychol. 18:1999;7-13.
45. Sander T., Harms H., Podschus J., Finckh U., Nickel B., Rolfs A., et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry. 41:1997;299-304.
46. Sano A., Kondoh K., Kakimoto Y., Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet. 91:1993;405-406.
47. Schmidt L.G., Harms H., Kuhn S., Rommelspacher H., Sander T. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatr. 155:1998;474-478.
48. Sullivan P.F., Fifield W.J., Kennedy M.A., Mulder R.T., Sellman J.D., Joyce P.R. Novelty seeking and a dopamine transporter gene polymorphism (DAT1). Biol Psychiatry. 42:1997;1070-1072.
49. Thompson M., Vandenbergh D.J., Remington G., Comings D.E., George S.R., Uhl G.R., et al. Association study of Tourette syndrome and alcoholism with novel polymorphisms of the dopamine transporter. Abstr Soc Neurosci. 23:1997;408.
50. Vandenburgh D.J., Bendahhou E., Bird G.S., Cook E., Gelernter J., Uhl G.R. Human dopamine transporter gene 5′ and 3′ structures and molecular genetics. Abstr Soc Neurosci. 21:1995;374.
51. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics. 14:1992;1104-1106.
52. Vandenbergh D.J., Persico A.M., Uhl G.R. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res Mol Brain Res. 15:1992;161-166.
53. Waldman I.D., Robinson B.F., Feigoh S.A. Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder Extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity . Genet Epidemiol. 14:1997;699-704.
54. Wright S. Evolution and the Genetics of Populations The Theory of Gene Frequencies . vol. 2:1969;The University of Chicago Press, Chicago.
55. Wu L., Wells D., Tay J., Mendis D., Abbott M.-A., Barnitt A., et al. CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of α-CaMKII mRNA at synapses. Neuron. 21:1998;1129-1139.